{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T23:22:29Z","timestamp":1756682549009,"version":"3.37.3"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T00:00:00Z","timestamp":1624665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T00:00:00Z","timestamp":1624665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s11239-021-02514-3","type":"journal-article","created":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T01:02:15Z","timestamp":1624669335000},"page":"58-66","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pragmatic study of a thromboprophylaxis algorithm in critically ill patients with SARS-COV-2 infection"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9961-4947","authenticated-orcid":false,"given":"Maurizio","family":"Fattorutto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Bouckaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Brauner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Franck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Bouton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Heuse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Bouckaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"Bruyneel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,26]]},"reference":[{"key":"2514_CR1","unstructured":"Hunt B, Retter A, McClintock C (2020) Practical guidance for the prevention of thrombosis and management of coagulopathy and disseminated intravascular coagulation of patients infected with COVID-19. https:\/\/b-s-h.org.uk\/media\/18171\/th-and-covid-25-march-2020-final.pdf. Accessed 30 Mar 2020"},{"issue":"23","key":"2514_CR2","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1182\/blood.2020006000","volume":"135","author":"JM Connors","year":"2020","unstructured":"Connors JM, Levy JH (2020) COVID-19 and its implications for thrombosis and anticoagulation. Blood 135(23):2033\u20132040. https:\/\/doi.org\/10.1182\/blood.2020006000","journal-title":"Blood"},{"issue":"4","key":"2514_CR3","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N, Li D, Wang X et al (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18(4):844\u2013847. https:\/\/doi.org\/10.1111\/jth.14768","journal-title":"J Thromb Haemost"},{"issue":"11","key":"2514_CR4","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, Hu B, Hu C et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan, China. JAMA 323(11):1061\u20131069. https:\/\/doi.org\/10.1001\/jama.2020.1585","journal-title":"JAMA"},{"issue":"10229","key":"2514_CR5","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054\u20131062. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3","journal-title":"Lancet"},{"issue":"7","key":"2514_CR6","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1515\/cclm-2020-0188","volume":"58","author":"H Han","year":"2020","unstructured":"Han H, Yang L, Liu R et al (2020) Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med 58(7):1116\u20131120. https:\/\/doi.org\/10.1515\/cclm-2020-0188","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"2514_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jamcollsurg.2020.05.007","volume":"231","author":"FL Wright","year":"2020","unstructured":"Wright FL, Vogler TO, Moore EE et al (2020) Fibrinolysis shutdown correlates to thromboembolic events in severe COVID-19 infection. J Am Coll Surg 231(2):193-203.e1. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2020.05.007","journal-title":"J Am Coll Surg"},{"key":"2514_CR8","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"W-j Guan","year":"2020","unstructured":"Guan W-j, Ni Z-y, Hu Y et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382:1708\u20131720. https:\/\/doi.org\/10.1056\/NEJMoa2002032","journal-title":"N Engl J Med"},{"issue":"2","key":"2514_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s11739-020-02601-y","volume":"16","author":"M Levi","year":"2021","unstructured":"Levi M, Iba T (2021) COVID-19 coagulopathy: is it disseminated intravascular coagulation? Intern Emerg Med 16(2):309\u2013312. https:\/\/doi.org\/10.1007\/s11739-020-02601-y","journal-title":"Intern Emerg Med"},{"issue":"2","key":"2514_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.hrtlng.2021.01.011","volume":"50","author":"JK Salabei","year":"2021","unstructured":"Salabei JK, Fishman TJ, Asnake ZT et al (2021) COVID-19 Coagulopathy: current knowledge and guidelines on anticoagulation. Heart Lung 50(2):357\u2013360. https:\/\/doi.org\/10.1016\/j.hrtlng.2021.01.011","journal-title":"Heart Lung"},{"issue":"5","key":"2514_CR11","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/jth.14810","volume":"18","author":"J Thachil","year":"2020","unstructured":"Thachil J, Tang N, Gando S et al (2020) ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost 18(5):1023\u20131026. https:\/\/doi.org\/10.1111\/jth.14810","journal-title":"J Thromb Haemost"},{"key":"2514_CR12","unstructured":"Susen S, Tacquard CA, Godon A et al. (2020) Traitement anticoagulant pour la prevention du risque thrombotique chez un patient hospitalise avec covid-19 et surveillance de l\u2019hemostase propositions du GIHP et du GFHT. https:\/\/sfar.org\/traitement-anticoagulant-pour-la-prevention-du-risque-thrombotique-chez-un-patient-hospitalise-avec-covid-19-et-surveillance-de-lhemostase\/. Accessed 3 Apr 2020"},{"key":"2514_CR13","unstructured":"COVIDprotocols v2.0. Brigham and Women\u2019s Hospital\/Partners in Health\/UCSF Institute for Global Health Sciences (2021). https:\/\/www.covidprotocols.org. Accessed 30 Mar 2020"},{"issue":"5","key":"2514_CR14","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/jth.14817","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N, Bai H, Chen X et al (2020) Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 18(5):1094\u20131099. https:\/\/doi.org\/10.1111\/jth.14817","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2514_CR15","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","volume":"180","author":"C Wu","year":"2020","unstructured":"Wu C, Chen X, Cai Y et al (2020) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 180(7):934\u2013943. https:\/\/doi.org\/10.1001\/jamainternmed.2020.0994","journal-title":"JAMA Intern Med"},{"issue":"1","key":"2514_CR16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1080\/22221751.2020.1746199","volume":"9","author":"L Lin","year":"2020","unstructured":"Lin L, Lu L, Cao W et al (2020) Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect 9(1):727\u2013732. https:\/\/doi.org\/10.1080\/22221751.2020.1746199","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"2514_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40779-020-0233-6","volume":"7","author":"YH Jin","year":"2020","unstructured":"Jin YH, Cai L, Cheng ZS et al (2020) A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res 7(1):4. https:\/\/doi.org\/10.1186\/s40779-020-0233-6","journal-title":"Mil Med Res"},{"issue":"2","key":"2514_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/ejh.12992","volume":"100","author":"Y Harahsheh","year":"2018","unstructured":"Harahsheh Y, Ho KM (2018) Use of viscoelastic tests to predict clinical thromboembolic events: a systematic review and meta-analysis. Eur J Haematol 100(2):113\u2013123. https:\/\/doi.org\/10.1111\/ejh.12992","journal-title":"Eur J Haematol"},{"issue":"4","key":"2514_CR19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.4097\/kja.19169","volume":"72","author":"K G\u00f6rlinger","year":"2019","unstructured":"G\u00f6rlinger K, P\u00e9rez-Ferrer A, Dirkmann D et al (2019) The role of evidence-based algorithms for rotational thromboelastometry-guided bleeding management. Korean J Anesthesiol 72(4):297\u2013322. https:\/\/doi.org\/10.4097\/kja.19169","journal-title":"Korean J Anesthesiol"},{"issue":"1","key":"2514_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.tmrv.2016.08.005","volume":"31","author":"B Williams","year":"2017","unstructured":"Williams B, McNeil J, Crabbe A et al (2017) Practical use of thromboelastometry in the management of perioperative coagulopathy and bleeding. Transfus Med Rev 31(1):11\u201325. https:\/\/doi.org\/10.1016\/j.tmrv.2016.08.005","journal-title":"Transfus Med Rev"},{"issue":"6","key":"2514_CR21","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1177\/1076029618772336","volume":"24","author":"OM Akay","year":"2018","unstructured":"Akay OM (2018) The double hazard of bleeding and thrombosis in hemostasis from a clinical point of view: a global assessment by rotational thromboelastometry (ROTEM). Clin Appl Thromb Hemost 24(6):850\u2013858. https:\/\/doi.org\/10.1177\/1076029618772336","journal-title":"Clin Appl Thromb Hemost"},{"issue":"1","key":"2514_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1378\/chest.09-3081","volume":"139","author":"H Decousus","year":"2011","unstructured":"Decousus H, Tapson VF, Bergmann JF et al (2011) Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. Chest 139(1):69\u201379. https:\/\/doi.org\/10.1378\/chest.09-3081","journal-title":"Chest"},{"issue":"3","key":"2514_CR23","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1160\/TH16-01-0003.Accessed30March2020","volume":"116","author":"DJ Rosenberg","year":"2016","unstructured":"Rosenberg DJ, Press A, Fishbein J et al (2016) External validation of the IMPROVE bleeding risk assessment model in medical patients. Thromb Haemost 116(3):530\u2013536. https:\/\/doi.org\/10.1160\/TH16-01-0003.Accessed30March2020","journal-title":"Thromb Haemost"},{"key":"2514_CR24","unstructured":"Massachusetts General Hospital COVID-19 treatment guidance. https:\/\/www.massgeneral.org\/assets\/MGH\/pdf\/news\/coronavirus\/mass-general-COVID-19-treatment-guidance.pdf. Accessed 30 Mar 2020"},{"key":"2514_CR25","doi-asserted-by":"crossref","unstructured":"World Health Organization\u00a0(2020)\u00a0Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance.\u00a0World Health Organization. https:\/\/apps.who.int\/iris\/handle\/10665\/331446. Accessed 30 Mar 2020","DOI":"10.15557\/PiMR.2020.0003"},{"issue":"Suppl 3","key":"2514_CR26","doi-asserted-by":"publisher","first-page":"S390","DOI":"10.21037\/jtd.2018.12.24","volume":"11","author":"J Bourenne","year":"2019","unstructured":"Bourenne J, Carvelli J, Papazian L (2019) Evolving definition of acute respiratory distress syndrome. J Thorac Dis 11(Suppl 3):S390\u2013S393. https:\/\/doi.org\/10.21037\/jtd.2018.12.24","journal-title":"J Thorac Dis"},{"key":"2514_CR27","unstructured":"CDC 2019-Novel Coronavirus (2019-nCoV) real-time RT-PCR diagnostic panel. https:\/\/www.fda.gov\/media\/134922\/download. Accessed 30 Mar 2020"},{"issue":"4","key":"2514_CR28","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/jfb5040288","volume":"5","author":"K Roghani","year":"2014","unstructured":"Roghani K, Holtby RJ, Jahr JS (2014) Effects of hemoglobin-based oxygen carriers on blood coagulation. J Funct Biomater 5(4):288\u2013295. https:\/\/doi.org\/10.3390\/jfb5040288","journal-title":"J Funct Biomater"},{"issue":"3","key":"2514_CR29","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1590\/S1679-45082017MD3130","volume":"15","author":"T Crochemore","year":"2017","unstructured":"Crochemore T, Piza FMT, Rodrigues RDR et al (2017) A new era of thromboelastometry. Einstein (Sao Paulo) 15(3):380\u2013385. https:\/\/doi.org\/10.1590\/S1679-45082017MD3130","journal-title":"Einstein (Sao Paulo)"},{"issue":"6","key":"2514_CR30","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/10408363.2020.1770685","volume":"57","author":"G Ponti","year":"2020","unstructured":"Ponti G, Maccaferri M, Ruini C et al (2020) Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci 57(6):389\u2013399. https:\/\/doi.org\/10.1080\/10408363.2020.1770685","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"1","key":"2514_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/ki.2013.444","volume":"85","author":"A Levin","year":"2014","unstructured":"Levin A, Stevens PE (2014) Summary of KDIGO 2012 CKD guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int 85(1):49\u201361. https:\/\/doi.org\/10.1038\/ki.2013.444","journal-title":"Kidney Int"},{"issue":"5","key":"2514_CR32","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1164\/ajrccm.163.5.2101039","volume":"163","author":"RA Pauwels","year":"2001","unstructured":"Pauwels RA, Buist AS, Calverley PM, GOLD Scientific Committee et al (2001) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI\/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163(5):1256\u20131276. https:\/\/doi.org\/10.1164\/ajrccm.163.5.2101039","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"2514_CR33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/NT.0000000000000092.Accessed20May2021","volume":"50","author":"FQ Nuttall","year":"2015","unstructured":"Nuttall FQ (2015) Body mass index: obesity, BMI, and health: a critical review. Nutr Today 50(3):117\u2013128. https:\/\/doi.org\/10.1097\/NT.0000000000000092.Accessed20May2021","journal-title":"Nutr Today"},{"issue":"4","key":"2514_CR34","doi-asserted-by":"publisher","first-page":"220","DOI":"10.4103\/0972-5229.130573.Accessed20May2021","volume":"18","author":"AG Rapsang","year":"2014","unstructured":"Rapsang AG, Shyam DC (2014) Scoring systems in the intensive care unit: a compendium. Indian J Crit Care Med 18(4):220\u2013228. https:\/\/doi.org\/10.4103\/0972-5229.130573.Accessed20May2021","journal-title":"Indian J Crit Care Med"},{"issue":"3","key":"2514_CR35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1684\/stv.2009.0442","volume":"22","author":"L Drouet","year":"2010","unstructured":"Drouet L (2010) CIVD: quoi de neuf au congr\u00e8s de l\u2019ISTH? (Boston, 2009). Sang Thromb Vaiss 22(3):42\u201346. https:\/\/doi.org\/10.1684\/stv.2009.0442","journal-title":"Sang Thromb Vaiss"},{"issue":"11","key":"2514_CR36","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1111\/jth.14578","volume":"17","author":"T Iba","year":"2019","unstructured":"Iba T, Levy JH, Warkentin TE et al (2019) Scientific and Standardization Committee on DIC, and the Scientific and Standardization Committee on perioperative and critical care of the international society on thrombosis and haemostasis. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J Thromb Haemost 17(11):1989\u20131994. https:\/\/doi.org\/10.1111\/jth.14578","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2514_CR37","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3978\/j.issn.2072-1439.2013.04.05","volume":"5","author":"V Fanelli","year":"2013","unstructured":"Fanelli V, Vlachou A, Ghannadian S et al (2013) Acute respiratory distress syndrome: new definition, current and future therapeutic options. J Thorac Dis 5(3):326\u2013334. https:\/\/doi.org\/10.3978\/j.issn.2072-1439.2013.04.05","journal-title":"J Thorac Dis"},{"issue":"8","key":"2514_CR38","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW et al (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315(8):801\u2013810. https:\/\/doi.org\/10.1001\/jama.2016.0287","journal-title":"JAMA"},{"key":"2514_CR39","doi-asserted-by":"publisher","unstructured":"Schulman S, Kearon C (2005) Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3(4):692\u2013694. https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01204.x","DOI":"10.1111\/j.1538-7836.2005.01204.x"},{"key":"2514_CR40","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.thromres.2020.09.013","volume":"196","author":"V Pavoni","year":"2020","unstructured":"Pavoni V, Gianesello L, Pazzi M et al (2020) Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: a call to action. Thromb Res 196:313\u2013317. https:\/\/doi.org\/10.1016\/j.thromres.2020.09.013","journal-title":"Thromb Res"},{"key":"2514_CR41","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.thromres.2020.07.038","volume":"194","author":"B Stessel","year":"2020","unstructured":"Stessel B, Vanvuchelen C, Bruckers L et al (2020) Impact of implementation of an individualised thromboprophylaxis protocol in critically ill ICU patients with COVID-19: a longitudinal controlled before-after study. Thromb Res 194:209\u2013215. https:\/\/doi.org\/10.1016\/j.thromres.2020.07.038","journal-title":"Thromb Res"},{"issue":"6","key":"2514_CR42","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","volume":"46","author":"J Helms","year":"2020","unstructured":"Helms J, Tacquard C, Severac F et al (2020) High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 46(6):1089\u20131098. https:\/\/doi.org\/10.1007\/s00134-020-06062-x","journal-title":"Intensive Care Med"},{"issue":"9","key":"2514_CR43","doi-asserted-by":"publisher","first-page":"e783","DOI":"10.1097\/ccm.0000000000004466","volume":"48","author":"TK Maatman","year":"2020","unstructured":"Maatman TK, Jalali F, Feizpour C et al (2020) Routine venous thromboembolism prophylaxis may be inadequate in the hypercoagulable state of severe coronavirus disease 2019. Crit Care Med 48(9):e783\u2013e790. https:\/\/doi.org\/10.1097\/ccm.0000000000004466","journal-title":"Crit Care Med"},{"issue":"3","key":"2514_CR44","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/anae.15300","volume":"76","author":"B Atallah","year":"2021","unstructured":"Atallah B, Sadik ZG, Salem N et al (2021) The impact of protocol-based high-intensity pharmacological thromboprophylaxis on thrombotic events in critically ill COVID-19 patients. Anaesthesia 76(3):327\u2013335. https:\/\/doi.org\/10.1111\/anae.15300","journal-title":"Anaesthesia"},{"issue":"7","key":"2514_CR45","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1111\/jth.14850","volume":"18","author":"M Panigada","year":"2020","unstructured":"Panigada M, Bottino N, Tagliabue P et al (2020) Hypercoagulability of COVID-19 patients in intensive care unit. A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost 18(7):1738\u20131742. https:\/\/doi.org\/10.1111\/jth.14850","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2514_CR46","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1055\/s-0040-1710018","volume":"120","author":"L Spiezia","year":"2020","unstructured":"Spiezia L, Boscolo A, Poletto F et al (2020) COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thromb Haemost 120(6):998\u20131000. https:\/\/doi.org\/10.1055\/s-0040-1710018","journal-title":"Thromb Haemost"},{"issue":"2","key":"2514_CR47","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s11239-020-02130-7","volume":"50","author":"V Pavoni","year":"2020","unstructured":"Pavoni V, Gianesello L, Pazzi M et al (2020) Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia. J Thromb Thrombolysis 50(2):281\u2013286. https:\/\/doi.org\/10.1007\/s11239-020-02130-7","journal-title":"J Thromb Thrombolysis"},{"issue":"6","key":"2514_CR48","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/trf.15847","volume":"60","author":"JS Raval","year":"2020","unstructured":"Raval JS, Burnett AE, Rollins-Raval MA et al (2020) Viscoelastic testing in COVID-19: a possible screening tool for severe disease? Transfusion 60(6):1131\u20131132. https:\/\/doi.org\/10.1111\/trf.15847","journal-title":"Transfusion"},{"issue":"12","key":"2514_CR49","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1053\/j.jvca.2020.05.020","volume":"34","author":"RJ Madathil","year":"2020","unstructured":"Madathil RJ, Tabatabai A, Rabin J et al (2020) Thromboelastometry and D-dimer elevation in coronavirus-2019. J Cardiothorac Vasc Anesth 34(12):3495\u20133496. https:\/\/doi.org\/10.1053\/j.jvca.2020.05.020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2514_CR50","doi-asserted-by":"publisher","DOI":"10.4097\/kja.20327","author":"R Kong","year":"2020","unstructured":"Kong R, Hutchinson N, G\u00f6rlinger K (2020) Hyper- and hypocoagulability in COVID-19 as assessed by thromboelastometry. Two case reports. Korean J Anesthesiol. https:\/\/doi.org\/10.4097\/kja.20327","journal-title":"Korean J Anesthesiol"},{"issue":"2","key":"2514_CR51","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.aucc.2020.07.003","volume":"34","author":"LW Collett","year":"2021","unstructured":"Collett LW, Gluck S, Strickland RM et al (2021) Evaluation of coagulation status using viscoelastic testing in intensive care patients with coronavirus disease 2019 (COVID-19): an observational point prevalence cohort study. Aust Crit Care 34(2):155\u2013159. https:\/\/doi.org\/10.1016\/j.aucc.2020.07.003","journal-title":"Aust Crit Care"},{"issue":"3","key":"2514_CR52","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/SHK.0000000000001635","volume":"55","author":"C Creel-Bulos","year":"2021","unstructured":"Creel-Bulos C, Auld SC, Caridi-Scheible M et al (2021) Fibrinolysis shutdown and thrombosis in a COVID-19 ICU. Shock 55(3):316\u2013320. https:\/\/doi.org\/10.1097\/SHK.0000000000001635","journal-title":"Shock"},{"issue":"10","key":"2514_CR53","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1111\/jth.15043","volume":"18","author":"A Blasi","year":"2020","unstructured":"Blasi A, von Meijenfeldt FA, Adelmeijer J et al (2020) In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID-19 patients on anticoagulation. J Thromb Haemost 18(10):2646\u20132653. https:\/\/doi.org\/10.1111\/jth.15043","journal-title":"J Thromb Haemost"},{"key":"2514_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.thromres.2020.07.035","volume":"196","author":"EA Vlot","year":"2020","unstructured":"Vlot EA, Van den Dool EJ, Hackeng CM et al (2020) Anti Xa activity after high dose LMWH thrombosis prophylaxis in covid 19 patients at the intensive care unit. Thromb Res 196:1\u20133. https:\/\/doi.org\/10.1016\/j.thromres.2020.07.035","journal-title":"Thromb Res"},{"issue":"2","key":"2514_CR55","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s11239-020-02226-0","volume":"51","author":"C Iba\u00f1ez","year":"2021","unstructured":"Iba\u00f1ez C, Perdomo J, Calvo A et al (2021) High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there? J Thromb Thrombolysis 51(2):308\u2013312. https:\/\/doi.org\/10.1007\/s11239-020-02226-0","journal-title":"J Thromb Thrombolysis"},{"issue":"9","key":"2514_CR56","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1111\/jth.15016","volume":"18","author":"C Nougier","year":"2020","unstructured":"Nougier C, Benoit R, Simon M et al (2020) Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis. J Thromb Haemost 18(9):2215\u20132219. https:\/\/doi.org\/10.1111\/jth.15016","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2514_CR57","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1111\/jth.14854","volume":"18","author":"M Ranucci","year":"2020","unstructured":"Ranucci M, Ballotta A, Di Dedda U et al (2020) The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost 18(7):1747\u20131751. https:\/\/doi.org\/10.1111\/jth.14854","journal-title":"J Thromb Haemost"},{"key":"2514_CR58","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1111\/jth.14859","volume":"18","author":"L Zhang","year":"2020","unstructured":"Zhang L, Yan X, Fan Q et al (2020) D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost 18:1324\u20131329. https:\/\/doi.org\/10.1111\/jth.14859","journal-title":"J Thromb Haemost"},{"key":"2514_CR59","unstructured":"https:\/\/www.isth.org\/news\/517212\/A-Systematic-Approach-for-Managing-Venous-Thromboembolism-in-Patients-with-COVID-19.htm. Accessed 3 Oct 2020"},{"key":"2514_CR60","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.thromres.2020.09.026","volume":"196","author":"ACB Lemos","year":"2020","unstructured":"Lemos ACB, do Esp\u00edrito Santo DA, Salvetti MC et al (2020) Therapeutic versus prophylactic anticoagulation for severe COVID-19: a randomized phase II clinical trial (HESACOVID). Thromb Res 196:359\u2013366. https:\/\/doi.org\/10.1016\/j.thromres.2020.09.026","journal-title":"Thromb Res"},{"key":"2514_CR61","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.thromres.2020.09.033","volume":"196","author":"B Bikdeli","year":"2020","unstructured":"Bikdeli B (2020) Anticoagulation in COVID-19: randomized trials should set the balance between excitement and evidence. Thromb Res 196:638\u2013640. https:\/\/doi.org\/10.1016\/j.thromres.2020.09.033","journal-title":"Thromb Res"},{"issue":"15","key":"2514_CR62","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/j.jacc.2021.02.035","volume":"77","author":"AH Talasaz","year":"2021","unstructured":"Talasaz AH, Sadeghipour P, Kakavand H et al (2021) Recent randomized trials of antithrombotic therapy for patients\u00a0with\u00a0COVID-19: JACC state-of-the-art review. J Am Coll Cardiol 77(15):1903\u20131921. https:\/\/doi.org\/10.1016\/j.jacc.2021.02.035","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-021-02514-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-021-02514-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-021-02514-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T14:05:07Z","timestamp":1643205907000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-021-02514-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,26]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["2514"],"URL":"https:\/\/doi.org\/10.1007\/s11239-021-02514-3","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"type":"print","value":"0929-5305"},{"type":"electronic","value":"1573-742X"}],"subject":[],"published":{"date-parts":[[2021,6,26]]},"assertion":[{"value":"16 June 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest\/competing interests. Authors declare to adhere to the minimum reporting guidelines hosted by the EQUATOR Network when preparing their observational study (STROBE statement).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective study, involving human participants, was in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The ethics committee of the Centre Hospitalier Universitaire Tivoli, La Louvi\u00e8re, Hainaut, Belgium (Universit\u00e9 Libre Bruxelles, Bruxelles, Belgium) approved this study on July 29, 2020 (Number 1362).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Formal informed consent was exempted by the ethics committee of our hospital due to the retrospective nature of the study and given the risks of awakening a painful past or of calling on a family to process data from a deceased person. No patient expressed opposition to the use of their medical records for research and\/or publication purposes. This wish was respected by checking in each computerized medical file whether an objection form was archived in the \u201cclinical research\u201d section.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}